Edesa Biotech Inc.

NASDAQ: EDSA · Real-Time Price · USD
2.24
-0.02 (-0.88%)
At close: Aug 15, 2025, 3:59 PM
2.23
-0.22%
After-hours: Aug 15, 2025, 04:04 PM EDT

Edesa Biotech Income Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 183.47K 118.19K 118.79K
Gross Profit
n/a -183.47K -118.19K -118.79K
Operating Income
-7.01M -9.22M -18.37M -23.68M
Interest Income
153.5K 289.85K 63.52 11.16K
Pretax Income
-6.17M -8.37M -17.55M -13.34M
Net Income
-6.17M -8.37M -17.55M -13.34M
Selling & General & Admin
4.13M 4.24M 5.04M 5.73M
Research & Development
2.88M 4.79M 13.34M 17.95M
Other Expenses
n/a n/a -780.26K -10.34M
Operating Expenses
7.01M 9.22M 17.59M 13.34M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a -183.47K n/a n/a
Cost & Expenses
7.01M 9.22M 17.59M 13.34M
Income Tax Expense
800.00 800.00 800.00 800.00
Shares Outstanding (Basic)
3.2M 2.86M 2.1M 1.73M
Shares Outstanding (Diluted)
3.2M 2.86M 2.1M 1.73M
EPS (Basic)
-1.93 -2.93 -8.37 -7.74
EPS (Diluted)
-1.93 -2.93 -8.37 -7.73
EBITDA
-5.98M -8.19M -17.43M -13.22M
EBIT
-6.32M -8.37M -17.55M -13.34M
Depreciation & Amortization
186.05K 183.47K 118.19K 118.79K